Literature DB >> 15804568

Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures.

Aditi Mukherjee1, Sai Sai Dong, Thomas Clemens, Jesus Alvarez, Rosa Serra.   

Abstract

Transforming growth factor-beta (TGF-beta) is known to regulate chondrocyte proliferation and hypertrophic differentiation in embryonic bone cultures by a perichondrium dependent mechanism. To begin to determine which factors in the perichondrium mediate the effects of TGF-beta, we studied the effect of Insulin-like Growth Factor-1 (IGF-I) and Fibroblast Growth Factors-2 and -18 (FGF2, FGF18) on metatarsal organ cultures. An increase in chondrocyte proliferation and hypertrophic differentiation was observed after treatment with IGF-I. A similar effect was seen after the perichondrium was stripped from the metatarsals suggesting IGF-I acts directly on the chondrocytes. Treatment with FGF-2 or FGF-18 resulted in a decrease in bone elongation as well as hypertrophic differentiation. Treatment also resulted in a decrease in BrdU incorporation into chondrocytes and an increase in BrdU incorporation in perichondrial cells, similar to what is seen after treatment with TGF-beta1. A similar effect was seen with FGF2 after the perichondrium was stripped suggesting that, unlike TGF-beta, FGF2 acts directly on chondrocytes to regulate proliferation and hypertrophic differentiation. To test the hypothesis that TGF-beta regulates IGF or FGF signaling, activation of the receptors was characterized after treatment with TGF-beta. Activation was measured as the level of tyrosine phosphorylation on the receptor. Treatment with TGF-beta for 24h did not alter the level of IGFR-I tyrosine phosphorylation. In contrast, treatment with TGF-beta resulted in and increase in tyrosine phosphorylation on FGFR3 without alterations in total FGFR3 levels. TGF-beta also stimulated expression of FGF18 mRNA in the cultures and the effects of TGF-beta on metatarsal development were blocked or partially blocked by pretreatment with FGF signaling inhibitors. The results suggest a model in which FGF through FGFR3 mediates some of the effects of TGF-beta on embryonic bone formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15804568     DOI: 10.1016/j.mod.2004.11.006

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  17 in total

1.  Congenic mice provide in vivo evidence for a genetic locus that modulates intrinsic transforming growth factor β1-mediated signaling and bone acquisition.

Authors:  Aditi Mukherjee; Emily A Larson; Amy S Carlos; John K Belknap; Peter Rotwein; Robert F Klein
Journal:  J Bone Miner Res       Date:  2012-06       Impact factor: 6.741

2.  The role of TGF-beta signaling in regulating chondrogenesis and osteogenesis during mandibular development.

Authors:  Kyoko Oka; Shoji Oka; Tomoyo Sasaki; Yoshihiro Ito; Pablo Bringas; Kazuaki Nonaka; Yang Chai
Journal:  Dev Biol       Date:  2006-11-21       Impact factor: 3.582

Review 3.  Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-beta signaling.

Authors:  Shaheen Ahmed; Ali Nawshad
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

4.  Akt promotes BMP2-mediated osteoblast differentiation and bone development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  J Cell Sci       Date:  2009-02-10       Impact factor: 5.285

5.  Identification of unique molecular subdomains in the perichondrium and periosteum and their role in regulating gene expression in the underlying chondrocytes.

Authors:  Amitabha Bandyopadhyay; James K Kubilus; Marsha L Crochiere; Thomas F Linsenmayer; Clifford J Tabin
Journal:  Dev Biol       Date:  2008-06-16       Impact factor: 3.582

6.  Inhibition of α-SMA by the ectodomain of FGFR2c attenuates lung fibrosis.

Authors:  Wang Ju; Yu Zhihong; Zhou Zhiyou; Huang Qin; Wang Dingding; Sun Li; Zhu Baowei; Wei Xing; He Ying; Hong An
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

7.  Involvement of fibroblast growth factor 18 in dedifferentiation of cultured human chondrocytes.

Authors:  H Yamaoka; S Nishizawa; Y Asawa; Y Fujihara; T Ogasawara; K Yamaoka; S Nagata; T Takato; K Hoshi
Journal:  Cell Prolif       Date:  2009-11-10       Impact factor: 6.831

8.  Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2008-02-21

9.  Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.

Authors:  A J Brown; M Alicknavitch; S S D'Souza; T Daikoku; C B Kirn-Safran; D Marchetti; D D Carson; M C Farach-Carson
Journal:  Bone       Date:  2008-06-06       Impact factor: 4.398

10.  Synovium-derived stem cell-based chondrogenesis.

Authors:  Ming Pei; Fan He; Gordana Vunjak-Novakovic
Journal:  Differentiation       Date:  2008-07-02       Impact factor: 3.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.